FRED ALGER MANAGEMENT, LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 3520 NEW YORK, NY

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,593,167

+$46,514,546 QoQ

Shares Held

259,468

+1113.9% QoQ

Ownership

0.121%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#88

of 675 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. RVMD ranks #3 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	3,301,919	$269,139,417
2	DNTH	Dianthus Therapeutics, Inc. /DE/	1,302,493	$126,967,017
3	RVMD	Revolution Medicines, Inc. This page	259,468	$48,593,167
4	ASND	Ascendis Pharma A/S	171,447	$45,728,343
5	COGT	Cogent Biosciences, Inc.	1,072,830	$41,518,521
6	ROIV	Roivant Sciences Ltd.	1,081,421	$38,271,489
7	FBRX	Forte Biosciences, Inc.	1,439,697	$30,593,561
8	ERAS	Erasca, Inc.	1,308,455	$23,970,895

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,593,167	259,468	+1113.9%	Shares	Sole	2026-08-14
2026-03-31	$2,078,621	21,374	+31.5%	Shares	Sole	2026-05-15
2025-12-31	$1,294,312	16,250	-86.1%	Shares	Sole	2026-02-17
2025-09-30	$5,453,626	116,780	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$4,291,369	116,645	-0.6%	Shares	Sole	2025-08-14
2025-03-31	$4,151,228	117,399	-20.7%	Shares	Sole	2025-05-16
2024-12-31	$6,479,031	148,126	-72.6%	Shares	Sole	2025-02-14
2024-09-30	$24,519,520	540,673	+2384.3%	Shares	Sole	2024-11-14
2024-06-30	$844,660	21,764	+379.2%	Shares	Sole	2024-08-14
2023-09-30	$125,722	4,542	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.